Bioasis Technologies Inc. (BIOAF)

Bioasis Technologies Cash Flow Statement

Financials in millions CAD. Fiscal year is March - February.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Nov 30, 2022	Feb 28, 2022	Feb 28, 2021	Feb 29, 2020	Feb 28, 2019	Feb 28, 2018
Net Income	-2.88	-2.96	0.7	-4.06	-3.47	-5.31
Depreciation & Amortization	0.09	0.05	0.06	0.07	0.07	0.06
Other Amortization	0.94	0.65	0.11	0.06	0	0
Loss (Gain) From Sale of Assets	-	0	0.01	-	-0.4	-
Stock-Based Compensation	0.27	0.44	0.28	0.57	0.98	1.47
Other Operating Activities	-1.18	-1.42	0.87	-0.62	-0.98	-
Change in Accounts Receivable	0.05	-0.07	-0.02	-0	0.02	0.02
Change in Accounts Payable	0.25	-0.51	0.01	1.01	0.21	0.21
Change in Unearned Revenue	0.25	-	-	-0.26	0.26	-0.17
Change in Other Net Operating Assets	0.28	0.18	-0.24	-0.05	0.07	0.04
Operating Cash Flow	-1.94	-3.64	1.77	-3.3	-3.23	-3.67
Capital Expenditures	-	-	-	-	-0	-0.04
Sale of Property, Plant & Equipment	-	-	0.01	-	-	-
Sale (Purchase) of Intangibles	-	-	-	-	0.4	-0.06
Investing Cash Flow	-	-	0.01	-	0.39	-0.11
Short-Term Debt Issued	-	-	-	0.62	-	-
Long-Term Debt Issued	-	2.91	0.12	0.67	-	-
Total Debt Issued	-	2.91	0.12	1.29	-	-
Long-Term Debt Repaid	-	-0.38	-0.7	-	-	-
Net Debt Issued (Repaid)	-0.75	2.53	-0.58	1.29	-	-
Issuance of Common Stock	0.2	0.2	0.89	1.21	3.53	3.9
Other Financing Activities	-	-0.09	-	-	-	-
Financing Cash Flow	-0.55	2.64	0.31	2.49	3.53	3.9
Foreign Exchange Rate Adjustments	0.05	-0.01	0.07	0.02	-0.01	-
Net Cash Flow	-2.44	-1.01	2.16	-0.78	0.68	0.12
Free Cash Flow	-1.94	-3.64	1.77	-3.3	-3.23	-3.72
Free Cash Flow Margin	-718.89%	-9636.86%	43.44%	-543.99%	-227.26%	-630.11%
Free Cash Flow Per Share	-0.03	-0.05	0.03	-0.05	-0.06	-0.07
Cash Interest Paid	0	-	0.01	-	-	-
Levered Free Cash Flow	-0.31	-1.91	0.2	-1.54	-1.02	-1.77
Unlevered Free Cash Flow	-0.66	-2.16	0.18	-1.56	-1.02	-1.77
Change in Net Working Capital	-0.9	0.41	0.39	-0.68	-0.57	-0.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.